K130132 is an FDA 510(k) clearance for the BABYLANCE HEEL INCISION DEVICE. This device is classified as a Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature (Class II - Special Controls, product code FMK).
Submitted by Medipurpose Pte. , Ltd. (Alpharetta, US). The FDA issued a Cleared decision on February 11, 2013, 24 days after receiving the submission on January 18, 2013.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4850. A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Non-reusable Base (including An Integral Sharps Injury Prevention Feature) That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes. The Integral Sharps Injury Prevention Feature Allows The Device To Be Used Once And Then Renders It Inoperable And Incapable Of Further Use..